We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Regen BioPharma

News List

Regen BioPharma Files Immuno-Oncology Patent Application americanpharmaceuticalreview
August 09, 2019
Regen BioPharma has announced the filing of a US patent application covering a newly discovered synergy between inhibition of NR2F6 and cannabidiol (CBD). The new data demonstrates enhanced ability to reduce cancer growth in ...
Regen BioPharma Files New Composition of Matter Patent Application europeanpharmaceuticalreview
September 10, 2018
Regen BioPharma has filed a patent application covering composition of matter and methods of use related to molecules identified in its small molecule program that activate NR2F6 ("Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans").
Regen BioPharma Reports Success of NR2F6 Small Molecule Screening Program americanpharmaceuticalreview
September 03, 2018
Regen BioPharma has identified a series of small molecule drugs that inhibit NR2F6. Regen's screening process demonstrated that its recently identified novel chemical compounds appear to inhibit NR2F6 and show potential for treating autoimmune diseases su